Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes

Trends in Parasitology

Volumn 24, Issue 8, 2008, Pages 345-349

  de Koning, Harry P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; ADENOSINE TRIPHOSPHATE; ARSENOSOBENZENE; CARRIER PROTEIN; DIAMIDINE DERIVATIVE; DIMINAZENE; DIMINAZENE ACETURATE; MELARSAMINE; MELARSENOXIDE; MELARSOPROL; ORGANOARSENIC DERIVATIVE; PENTAMIDINE; PROPAMIDINE;

AFRICAN TRYPANOSOMIASIS; ANTIPROTOZOAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG RESEARCH; DRUG UPTAKE; HUMAN; NONHUMAN; TRYPANOSOMA;

ANIMALS; ARSENICALS; DRUG RESISTANCE; HUMANS; MOLECULAR STRUCTURE; PENTAMIDINE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 47649132991     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2008.04.006     Document Type: Article

References (42)

1. Soeiro M.N.C., et al. Aromatic diamidines as antiparasitic agents. Expert Opin. Investig. Drugs 14 (2005) 957-972
2. Bray P.G., et al. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. 19 (2003) 232-239
3. Delespaux V., and De Koning H.P. Drugs and drug resistance in African trypanosomiasis. Drug Resist. Updat. 10 (2007) 30-50
4. Werbovetz K. Diamidines as trypanosomal, antileishmanial and antimalarial agents. Curr. Opin. Investig. Drugs 7 (2006) 147-157
5. Ansede J.H., et al. O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection. J. Med. Chem. 47 (2004) 4335-4338
6. Brun R., et al. The phenomenon of treatment failures in human African trypanosomiasis. Trop. Med. Int. Health 6 (2001) 906-914
7. Barrett M.P., and Fairlamb A.H. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol. Today 15 (1999) 136-140
8. Geerts S., et al. African bovine trypanosomiasis: the problem of drug resistance. Trends Parasitol. 17 (2001) 25-28
9. Welburn S.C., et al. Identification of human-infective trypanosomiasis in animal reservoir of sleeping of sleeping sickness in Uganda by means of serum-resistance (SRA) gene. Lancet 358 (2001) 2017-2019
10. Simo G., et al. High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon. Vet. Parasitol. 139 (2006) 57-66
11. Barrett M.P. Veterinary link to drug resistance in human African trypanosomiasis?. Lancet 358 (2001) 603-604
12. De Koning H.P. Transporters in African trypanosomes: role in drug action and resistance. Int. J. Parasitol. 31 (2001) 512-522
13. Kibona S.N., et al. Drug reistance of Trypanosoma b. rhodesiense isolates from Tanzania. Trop. Med. Int. Health 11 (2006) 144-155
14. Kagira J.M., and Maina N. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients. Onderstepoort J. Vet. Res. 74 (2007) 17-22
15. Carter N.S., et al. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270 (1995) 28153-28157
16. Bridges D.J., et al. Loss of the high affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes. Mol. Pharmacol. 71 (2007) 1098-1108
17. Damper D., and Patton C.L. Pentamidine transport and sensitivity in brucei-group trypanosomes. J. Protozool. 23 (1976) 349-356
18. Mathis A.M., et al. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrob. Agents Chemother. 50 (2006) 2185-2191
19. Carter N.S., and Fairlamb A.H. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361 (1993) 173-176
20. Barrett M.P., et al. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol. Biochem. Parasitol. 73 (1995) 223-229
21. De Koning H.P., and Jarvis S.M. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. Acta Trop. 80 (2001) 245-250
22. De Koning H.P. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters. Implications for cross-resistance with arsenicals. Mol. Pharmacol. 59 (2001) 586-592
23. De Koning H.P., et al. The trypanocide diminazene aceturate is accumulated only through the TbAT1 purine transporter; additional insights in diamidine resistance in African trypanosomes. Antimicrob. Agents Chemother. 48 (2004) 1515-1519
24. Mäser P., et al. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science 285 (1999) 242-244
25. Matovu E., et al. The mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot. Cell 2 (2003) 1003-1008
26. Lanteri C.A., et al. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Mol. Pharmacol. 70 (2006) 1585-1592
27. Matovu E., et al. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy. Mol. Biochem. Parasitol. 117 (2001) 73-81
28. Nerima B., et al. Detection of mutant P2 adenosine transporter (TbAT1) gene in Trypanosoma brucei gambiense isolates from northwest Uganda using allele-specific polymerase chain reaction. Trop. Med. Int. Health 12 (2007) 1361-1368
29. Williamson J. Drug resistance in trypanosomes: selective interference with trypanocidal action. Br. J. Pharmacol. Chemother. 14 (1959) 431-442
30. De Koning H.P., and Jarvis S.M. Adenosine transporters in bloodstream forms of T. b. brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol. Pharmacol. 56 (1999) 1162-1170
31. Klokouzas A., et al. ABC transporters and drug resistance in parasitic protozoa. Int. J. Antimicrob. Agents 22 (2003) 301-317
32. Jones P.M., and George A.M. Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. Int. J. Parasitol. 35 (2005) 555-566
33. Mäser P., and Kaminsky R. Identification of three ABC transporter genes in Trypanosoma brucei spp. Parasitol. Res. 84 (1998) 106-111
34. Shahi S.K., et al. Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei. Mol. Microbiol. 43 (2002) 1129-1138
35. Fairlamb A.H., et al. Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2607-2611
36. Lüscher A., et al. Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei. Mol. Biochem. Parasitol. 150 (2006) 364-366
37. Alibu V.P., et al. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility. Mol. Biochem. Parasitol. 146 (2006) 38-44
38. Fairlamb A.H., et al. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. 53 (1992) 213-222
39. Scott A.G., et al. Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin. Acta Trop. 60 (1996) 251-262
40. Delespaux V., et al. SSCP analysis of the P2 purine transporter TcoAT1 gene of Trypanosoma congolense leads to a simple PCR-RFLP test allowing the rapid identification of diminazene resistant stocks. Acta Trop. 100 (2006) 96-102
41. Scott A.G., et al. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites. Exp. Parasitol. 86 (1997) 181-190
42. Bronner U., et al. Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized. Trop. Med. Int. Health 3 (1998) 913-917